impact factor, citescore
logo
In press
In Press
Recent issue
Recent issue
Recent Supplement
Recent supplement
archives
Archives
articles free
Free to view
Search
Search
 

Review

 

Gout: one year in review 2025

1, 2, 3, 4, 5, 6, 7

 

  1. Centre for Gout & Metabolic, Bone and Joint Diseases, Ospedale Civile SS Giovanni e Paolo, Venice, Italy.
  2. Rheumatology Unit, Department of Medicine, DIMED, University of Padova, Italy.
  3. Laboratory Medicine Unit, Department of Medicine-DIMED, University of Padova, Italy.
  4. Rheumatology Unit, Department of Medicine, DIMED, University of Padova, Italy.
  5. Rheumatology Unit, Department of Medicine, DIMED, University of Padova, Italy.
  6. Rheumatology Unit, Department of Medicine, DIMED, University of Padova, Italy.
  7. Rheumatology Unit, Department of Medicine, DIMED, University of Padova, Italy. roberta.ramonda@unipd.it

CER18647
Review

Free to view
(click on article PDF icon to read the article)

PMID: 40153315 [PubMed]

Received: 19/02/2025
Accepted : 13/03/2025
In Press: 28/03/2025

Abstract

The incidence of gout has increased steadily over the last decades and its management is still unsatisfactory. Growing evidence highlights the multifactorial etiology of this disease encompassing genetic predisposition, environmental stimuli and gut dysbiosis. Recent advances in biomolecular and computer sciences allowed to gain more and more genetic, epigenetic, transcriptomic, proteomics and metabolomics insights into hyperuricaemia and gout-related molecular mechanisms. Moreover, the interplay between gout and cardiovascular, metabolic and renal diseases may potentially offer novel targets for anti-inflammatory and urate-lowering therapies. This annual review aims to provide the latest updates on gout research, epidemiology, genetics, molecular mechanisms, diagnostic approach, and therapeutic advances.

DOI: https://doi.org/10.55563/clinexprheumatol/9sdln5

Rheumatology Article